User profiles for Cedazo-Minguez Angel

Angel Cedazo-Minguez

Karolinska Institutet (Sweden)
Verified email at ki.se
Cited by 9273

DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy

…, D Miller, D Maric, A Cedazo-Minguez… - Human molecular …, 2011 - academic.oup.com
Mutations in DJ-1, PINK1 (PTEN-induced putative kinase 1) and parkin all cause recessive
parkinsonism in humans, but the relationships between these genes are not clearly defined. …

Defeating Alzheimer's disease and other dementias: a priority for European science and society

…, C Brayne, H Brodaty, A Cedazo-Minguez… - The Lancet …, 2016 - thelancet.com
Alzheimer's disease (AD) is the leading cause of dementia, and because the primary risk
factor for AD is old age, the prevalence of the disease is increasing dramatically with ageing …

Apolipoprotein E ɛ4 magnifies lifestyle risks for dementia: a population‐based study

…, V Hachinski, A CedazoMinguez… - Journal of cellular …, 2008 - Wiley Online Library
The risk of dementia and Alzheimer's disease (AD) probably results from an interaction
between genetic and environmental factors. The aim of this study was to investigate the effects …

[HTML][HTML] Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?

…, BO Popescu, A Cedazo-Minguez - Oxidative medicine and …, 2014 - hindawi.com
Alzheimer’s disease (AD) is the most common form of dementia in the elderly, with increasing
prevalence and no disease-modifying treatment available yet. A remarkable amount of …

Oxysterols and neurodegenerative diseases

I Björkhem, A Cedazo-Minguez, V Leoni… - Molecular aspects of …, 2009 - Elsevier
In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites
are able to cross the blood–brain barrier. There is a concentration-driven flux of 24S-…

[HTML][HTML] Involvement of glutaredoxin-1 and thioredoxin-1 in β-amyloid toxicity and Alzheimer's disease

…, B Winblad, A Cedazo-Minguez - Cell Death & …, 2006 - nature.com
Strong evidence indicates oxidative stress in the pathogenesis of Alzheimer's disease (AD).
Amyloid β (Aβ) has been implicated in both oxidative stress mechanisms and in neuronal …

[HTML][HTML] Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?

R Franco, A Cedazo-Minguez - Frontiers in pharmacology, 2014 - frontiersin.org
Peering into the field of Alzheimer’s disease (AD), the outsider realizes that many of the
therapeutic strategies tested (in animal models) have been successful. One also may notice that …

Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects

A Cedazo-Minguez, B Winblad - Experimental gerontology, 2010 - Elsevier
An early diagnosis of Alzheimer’s disease (AD) and other types of dementia-causing disorders
is vital in order to achieve effective treatments. Fortunately, in the recent years the search …

Toward a predictive model of Alzheimer's disease progression using capillary electrophoresis–mass spectrometry metabolomics

…, M Kivipelto, B Winblad, A Cedazo-Minguez… - Analytical …, 2012 - ACS Publications
Alzheimer’s disease (AD) is the most prevalent form of dementia with an estimated
worldwide prevalence of over 30 million people, and its incidence is expected to increase …

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia

…, K Höglund, A Bogstedt, A Cedazo-Minguez… - Alzheimer's & …, 2016 - Elsevier
Introduction Our objective was to compare the levels of three synaptic proteins involved in
different steps of the synaptic transmission: Rab3A, SNAP25, and neurogranin, in three …